(19)
(11) EP 1 430 024 A1

(12)

(43) Date of publication:
23.06.2004 Bulletin 2004/26

(21) Application number: 02764881.5

(22) Date of filing: 11.09.2002
(51) International Patent Classification (IPC)7C07C 275/42, C07C 335/22, C07C 279/18, A61K 31/192, A61P 11/00, A61P 17/00, A61P 35/00
(86) International application number:
PCT/EP2002/010179
(87) International publication number:
WO 2003/024921 (27.03.2003 Gazette 2003/13)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.09.2001 US 332963 P

(71) Applicant: F. HOFFMANN-LA ROCHE AG
4070 Basel (CH)

(72) Inventors:
  • BELLONI, Paula, Nanette
    Half Moon Bay, CA 94019 (US)
  • KERTESZ, Denis, John
    Moutain View, CA 94043 (US)
  • KLAUS, Michael
    79576 Weil am Rhein (DE)
  • LAPIERRE, Jean-Marc
    Pelham, NH 03076 (US)

(74) Representative: Kjellsaa-Berger, Hanny, Dr. 
F.Hoffmann-La Roche AGPatent Department (PLP),124 Grenzacherstrasse
4070 Basel
4070 Basel (CH)

   


(54) ALKYL UREA RETINOID AGONISTS I